Nanotherapeutics, Inc., a global manufacturer of biodefense and infectious disease products, received two new Task Orders from The U.S. Department of Health and Human Services (HHS), Biomedical Advanced Research and Development Authority (BARDA) Fill-Finish Manufacturing Network’s (FFMN) Pilot Production program.   BARDA, in consultation with the FDA’s Drug Shortage Staff, selected several products from the (FDA) Drug Shortage Index, for the network contractors to propose on. Upon completion and...